| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |